25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

PhaseRx Inc
Buy, Hold or Sell?

Let's analyze Phaserx together

I guess you are interested in PhaseRx Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of PhaseRx Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about PhaseRx Inc

I send you an email if I find something interesting about PhaseRx Inc.

1. Quick Overview

1.1. Quick analysis of Phaserx (30 sec.)










1.2. What can you expect buying and holding a share of Phaserx? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$0.80
Expected worth in 1 year
$20.70
How sure are you?
33.3%

+ What do you gain per year?

Total Gains per Share
$19.91
Return On Investment
9,954,577.7%

For what price can you sell your share?

Current Price per Share
$0.00
Expected price per share
$0.0002 - $0.0002
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Phaserx (5 min.)




Live pricePrice per Share (EOD)
$0.00

2.2. Growth of Phaserx (5 min.)




Is Phaserx growing?

Current yearPrevious yearGrowGrow %
How rich?$9.2m-$48.8m$58.1m625.9%

How much money is Phaserx making?

Current yearPrevious yearGrowGrow %
Making money-$20.1m-$7.3m-$12.7m-63.4%
Net Profit Margin0.0%-1,967.2%--

How much money comes from the company's main activities?

2.3. Financial Health of Phaserx (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Phaserx?

Welcome investor! Phaserx's management wants to use your money to grow the business. In return you get a share of Phaserx.

First you should know what it really means to hold a share of Phaserx. And how you can make/lose money.

Speculation

The Price per Share of Phaserx is $0.0002. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Phaserx.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Phaserx, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.80. Based on the TTM, the Book Value Change Per Share is $4.98 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.63 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Phaserx.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-1.72-861,269.6%-1.72-861,269.6%-0.63-315,518.0%-0.98-489,907.6%-0.98-489,907.6%
Usd Book Value Change Per Share4.982,488,644.4%4.982,488,644.4%-0.63-314,491.5%0.27132,545.8%0.27132,545.8%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share4.982,488,644.4%4.982,488,644.4%-0.63-314,491.5%0.27132,545.8%0.27132,545.8%
Usd Price Per Share1.55-1.55-0.00-0.52-0.52-
Price to Earnings Ratio-0.90--0.90-0.00--0.30--0.30-
Price-to-Total Gains Ratio0.31-0.31-0.31-0.31-
Price to Book Ratio1.95-1.95-0.00-0.65-0.65-
Price-to-Total Gains Ratio0.31-0.31-0.31-0.31-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.0002
Number of shares5000000
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share4.980.27
Usd Total Gains Per Share4.980.27
Gains per Quarter (5000000 shares)24,886,444.321,325,457.86
Gains per Year (5000000 shares)99,545,777.275,301,831.43
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
109954577799545767053018315301821
2019909155519909154401060366310603652
3029863733229863732101590549415905483
4039818310939818309802120732621207314
5049772888649772887502650915726509145
6059727466459727465203181098931810976
7069682044169682042903711282037112807
8079636621879636620604241465142414638
9089591199589591198304771648347716469
10099545777399545776005301831453018300

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.03.00.00.0%0.03.00.00.0%0.03.00.00.0%
Book Value Change Per Share1.00.00.0100.0%1.02.00.033.3%1.02.00.033.3%1.02.00.033.3%1.02.00.033.3%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.03.00.0%0.00.03.00.0%0.00.03.00.0%
Total Gains per Share1.00.00.0100.0%1.02.00.033.3%1.02.00.033.3%1.02.00.033.3%1.02.00.033.3%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of PhaseRx Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--4.9774.9770%-0.629+113%0.265+1778%0.265+1778%
Book Value Per Share--0.7950.7950%-4.182+626%-2.313+391%-2.313+391%
Current Ratio--7.9937.9930%0.154+5100%2.762+189%2.762+189%
Debt To Asset Ratio--0.4350.4350%13.491-97%10.182-96%10.182-96%
Debt To Equity Ratio--0.7690.7690%-+100%0.256+200%0.256+200%
Dividend Per Share----0%-0%-0%-0%
Eps---1.723-1.7230%-0.631-63%-0.980-43%-0.980-43%
Free Cash Flow Per Share---0.854-0.8540%-0.521-39%-0.599-30%-0.599-30%
Free Cash Flow To Equity Per Share--1.0421.0420%0.108+868%0.393+165%0.393+165%
Gross Profit Margin--1.3731.3730%1.000+37%1.124+22%1.124+22%
Market Cap2338.060-774900%18119965.00018119965.0000%-+100%6039988.333+200%6039988.333+200%
Net Profit Margin----0%-19.6720%-8.4600%-8.4600%
Operating Margin----0%-15.4850%-6.7150%-6.7150%
Operating Ratio----0%32.088-100%14.327-100%14.327-100%
Pb Ratio0.000-774900%1.9491.9490%-+100%0.650+200%0.650+200%
Pe Ratio0.000+100%-0.900-0.9000%--100%-0.300-67%-0.300-67%
Price Per Share0.000-774900%1.5501.5500%-+100%0.517+200%0.517+200%
Price To Free Cash Flow Ratio0.000+100%-1.815-1.8150%--100%-0.605-67%-0.605-67%
Price To Total Gains Ratio0.000-774900%0.3110.3110%--0.3110%0.3110%
Quick Ratio--10.36310.3630%0.137+7437%3.543+192%3.543+192%
Return On Assets---1.224-1.2240%-1.885+54%-1.895+55%-1.895+55%
Return On Equity---2.166-2.1660%--100%-0.722-67%-0.722-67%
Total Gains Per Share--4.9774.9770%-0.629+113%0.265+1778%0.265+1778%
Usd Book Value--9297000.0009297000.0000%-48889000.000+626%-27042666.667+391%-27042666.667+391%
Usd Book Value Change Per Share--4.9774.9770%-0.629+113%0.265+1778%0.265+1778%
Usd Book Value Per Share--0.7950.7950%-4.182+626%-2.313+391%-2.313+391%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---1.723-1.7230%-0.631-63%-0.980-43%-0.980-43%
Usd Free Cash Flow---9982000.000-9982000.0000%-6094000.000-39%-6996666.667-30%-6996666.667-30%
Usd Free Cash Flow Per Share---0.854-0.8540%-0.521-39%-0.599-30%-0.599-30%
Usd Free Cash Flow To Equity Per Share--1.0421.0420%0.108+868%0.393+165%0.393+165%
Usd Market Cap2338.060-774900%18119965.00018119965.0000%-+100%6039988.333+200%6039988.333+200%
Usd Price Per Share0.000-774900%1.5501.5500%-+100%0.517+200%0.517+200%
Usd Profit---20137000.000-20137000.0000%-7377000.000-63%-11454333.333-43%-11454333.333-43%
Usd Revenue----0%375000.000-100%525000.000-100%525000.000-100%
Usd Total Gains Per Share--4.9774.9770%-0.629+113%0.265+1778%0.265+1778%
 EOD+2 -6MRQTTM+0 -0YOY+20 -115Y+20 -1110Y+20 -11

3.3 Fundamental Score

Let's check the fundamental score of PhaseRx Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-150.000
Price to Book Ratio (EOD)Between0-10.000
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than110.363
Current Ratio (MRQ)Greater than17.993
Debt to Asset Ratio (MRQ)Less than10.435
Debt to Equity Ratio (MRQ)Less than10.769
Return on Equity (MRQ)Greater than0.15-2.166
Return on Assets (MRQ)Greater than0.05-1.224
Total5/10 (50.0%)

3.4 Technical Score

Let's check the technical score of PhaseRx Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose0.000
Total0/1 (0.0%)

4. In-depth Analysis

4.1 About PhaseRx Inc

PhaseRx, Inc., a biopharmaceutical company, engages in developing a portfolio of products for the treatment of inherited enzyme deficiencies in the liver using intracellular enzyme replacement therapy. The company develops its products based on its proprietary Hybrid mRNA technology platform, which allows the synthesis of missing enzyme inside the cell. Its therapeutic urea cycle disorder programs under development include PRX-OTC to treat ornithine transcarbamylase deficiency; PRX-ASL to treat argininosuccinate lyase deficiency; and PRX-ASS1 to treat argininosuccinate synthetase deficiency. The company was incorporated in 2006 and is headquartered in Seattle, Washington.

Fundamental data was last updated by Penke on 2024-11-27 17:55:07.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Phaserx earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Phaserx to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of PhaseRx Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-1,967.2%+1,967.2%
TTM-5Y-846.0%+846.0%
5Y-846.0%10Y-846.0%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--115.9%+115.9%
TTM--210.8%+210.8%
YOY-1,967.2%-214.5%-1,752.7%
5Y-846.0%-342.2%-503.8%
10Y-846.0%-464.5%-381.5%
4.3.1.2. Return on Assets

Shows how efficient Phaserx is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Phaserx to the Biotechnology industry mean.
  • -122.4% Return on Assets means that Phaserx generated $-1.22 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of PhaseRx Inc:

  • The MRQ is -122.4%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -122.4%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-122.4%TTM-122.4%0.0%
TTM-122.4%YOY-188.5%+66.0%
TTM-122.4%5Y-189.5%+67.1%
5Y-189.5%10Y-189.5%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-122.4%-11.1%-111.3%
TTM-122.4%-11.7%-110.7%
YOY-188.5%-11.3%-177.2%
5Y-189.5%-12.7%-176.8%
10Y-189.5%-14.3%-175.2%
4.3.1.3. Return on Equity

Shows how efficient Phaserx is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Phaserx to the Biotechnology industry mean.
  • -216.6% Return on Equity means Phaserx generated $-2.17 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of PhaseRx Inc:

  • The MRQ is -216.6%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -216.6%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-216.6%TTM-216.6%0.0%
TTM-216.6%YOY--216.6%
TTM-216.6%5Y-72.2%-144.4%
5Y-72.2%10Y-72.2%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-216.6%-14.2%-202.4%
TTM-216.6%-15.8%-200.8%
YOY--13.9%+13.9%
5Y-72.2%-18.5%-53.7%
10Y-72.2%-19.5%-52.7%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of PhaseRx Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Phaserx is operating .

  • Measures how much profit Phaserx makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Phaserx to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of PhaseRx Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-1,548.5%+1,548.5%
TTM-5Y-671.5%+671.5%
5Y-671.5%10Y-671.5%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--258.6%+258.6%
TTM--318.3%+318.3%
YOY-1,548.5%-224.0%-1,324.5%
5Y-671.5%-386.5%-285.0%
10Y-671.5%-497.6%-173.9%
4.3.2.2. Operating Ratio

Measures how efficient Phaserx is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of PhaseRx Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY32.088-32.088
TTM-5Y14.327-14.327
5Y14.32710Y14.3270.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.594-2.594
TTM-3.360-3.360
YOY32.0883.299+28.789
5Y14.3274.788+9.539
10Y14.3276.528+7.799
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of PhaseRx Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Phaserx is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 7.99 means the company has $7.99 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of PhaseRx Inc:

  • The MRQ is 7.993. The company is very able to pay all its short-term debts. +2
  • The TTM is 7.993. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ7.993TTM7.9930.000
TTM7.993YOY0.154+7.839
TTM7.9935Y2.762+5.231
5Y2.76210Y2.7620.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ7.9933.658+4.335
TTM7.9933.874+4.119
YOY0.1544.672-4.518
5Y2.7625.960-3.198
10Y2.7626.277-3.515
4.4.3.2. Quick Ratio

Measures if Phaserx is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Phaserx to the Biotechnology industry mean.
  • A Quick Ratio of 10.36 means the company can pay off $10.36 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of PhaseRx Inc:

  • The MRQ is 10.363. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 10.363. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ10.363TTM10.3630.000
TTM10.363YOY0.137+10.226
TTM10.3635Y3.543+6.820
5Y3.54310Y3.5430.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ10.3633.104+7.259
TTM10.3633.426+6.937
YOY0.1374.498-4.361
5Y3.5435.933-2.390
10Y3.5436.426-2.883
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of PhaseRx Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Phaserx assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Phaserx to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.43 means that Phaserx assets are financed with 43.5% credit (debt) and the remaining percentage (100% - 43.5%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of PhaseRx Inc:

  • The MRQ is 0.435. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.435. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.435TTM0.4350.000
TTM0.435YOY13.491-13.056
TTM0.4355Y10.182-9.747
5Y10.18210Y10.1820.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4350.354+0.081
TTM0.4350.345+0.090
YOY13.4910.311+13.180
5Y10.1820.366+9.816
10Y10.1820.382+9.800
4.5.4.2. Debt to Equity Ratio

Measures if Phaserx is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Phaserx to the Biotechnology industry mean.
  • A Debt to Equity ratio of 76.9% means that company has $0.77 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of PhaseRx Inc:

  • The MRQ is 0.769. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.769. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.769TTM0.7690.000
TTM0.769YOY-+0.769
TTM0.7695Y0.256+0.513
5Y0.25610Y0.2560.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7690.398+0.371
TTM0.7690.437+0.332
YOY-0.378-0.378
5Y0.2560.452-0.196
10Y0.2560.495-0.239
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Phaserx generates.

  • Above 15 is considered overpriced but always compare Phaserx to the Biotechnology industry mean.
  • A PE ratio of -0.90 means the investor is paying $-0.90 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of PhaseRx Inc:

  • The EOD is 0.000. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.900. Based on the earnings, the company is expensive. -2
  • The TTM is -0.900. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD0.000MRQ-0.900+0.900
MRQ-0.900TTM-0.9000.000
TTM-0.900YOY--0.900
TTM-0.9005Y-0.300-0.600
5Y-0.30010Y-0.3000.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD0.000-2.160+2.160
MRQ-0.900-2.428+1.528
TTM-0.900-3.145+2.245
YOY--3.304+3.304
5Y-0.300-6.080+5.780
10Y-0.300-6.625+6.325
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of PhaseRx Inc:

  • The EOD is 0.000. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -1.815. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -1.815. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD0.000MRQ-1.815+1.815
MRQ-1.815TTM-1.8150.000
TTM-1.815YOY--1.815
TTM-1.8155Y-0.605-1.210
5Y-0.60510Y-0.6050.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD0.000-2.980+2.980
MRQ-1.815-3.295+1.480
TTM-1.815-3.682+1.867
YOY--4.523+4.523
5Y-0.605-8.162+7.557
10Y-0.605-9.239+8.634
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Phaserx is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 1.95 means the investor is paying $1.95 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of PhaseRx Inc:

  • The EOD is 0.000. Based on the equity, the company is cheap. +2
  • The MRQ is 1.949. Based on the equity, the company is underpriced. +1
  • The TTM is 1.949. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD0.000MRQ1.949-1.949
MRQ1.949TTM1.9490.000
TTM1.949YOY-+1.949
TTM1.9495Y0.650+1.299
5Y0.65010Y0.6500.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD0.0001.869-1.869
MRQ1.9492.027-0.078
TTM1.9492.365-0.416
YOY-2.419-2.419
5Y0.6503.668-3.018
10Y0.6504.362-3.712
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2016-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets16,448
Total Liabilities7,151
Total Stockholder Equity9,297
 As reported
Total Liabilities 7,151
Total Stockholder Equity+ 9,297
Total Assets = 16,448

Assets

Total Assets16,448
Total Current Assets16,177
Long-term Assets271
Total Current Assets
Cash And Cash Equivalents 9,983
Short-term Investments 5,496
Total Current Assets  (as reported)16,177
Total Current Assets  (calculated)15,479
+/- 698
Long-term Assets
Property Plant Equipment 271
Long-term Assets  (as reported)271
Long-term Assets  (calculated)271
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities2,024
Long-term Liabilities5,127
Total Stockholder Equity9,297
Total Current Liabilities
Short-term Debt 576
Short Long Term Debt 576
Accounts payable 515
Other Current Liabilities 933
Total Current Liabilities  (as reported)2,024
Total Current Liabilities  (calculated)2,600
+/- 576
Long-term Liabilities
Long term Debt 5,127
Long-term Liabilities  (as reported)5,127
Long-term Liabilities  (calculated)5,127
+/-0
Total Stockholder Equity
Common Stock1
Retained Earnings -69,480
Accumulated Other Comprehensive Income 3
Other Stockholders Equity 78,773
Total Stockholder Equity (as reported)9,297
Total Stockholder Equity (calculated)9,297
+/-0
Other
Cash and Short Term Investments 15,479
Common Stock Shares Outstanding 7,524
Liabilities and Stockholders Equity 16,448
Net Debt -4,280
Net Tangible Assets 9,297
Net Working Capital 14,153
Short Long Term Debt Total 5,703



6.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2016-12-312015-12-312014-12-31
> Total Assets 
2,659
3,914
16,448
16,4483,9142,659
   > Total Current Assets 
2,206
3,678
16,177
16,1773,6782,206
       Cash And Cash Equivalents 
2,031
3,290
9,983
9,9833,2902,031
       Short-term Investments 
0
0
5,496
5,49600
       Other Current Assets 
175
388
0
0388175
   > Long-term Assets 
453
236
271
271236453
       Property Plant Equipment 
453
236
271
271236453
> Total Liabilities 
44,195
52,803
7,151
7,15152,80344,195
   > Total Current Liabilities 
15,795
23,928
2,024
2,02423,92815,795
       Short-term Debt 
12,540
19,841
576
57619,84112,540
       Short Long Term Debt 
12,540
19,841
576
57619,84112,540
       Accounts payable 
197
396
515
515396197
       Other Current Liabilities 
5,366
3,691
933
9333,6915,366
   > Long-term Liabilities 
28,400
28,875
5,127
5,12728,87528,400
       Other Liabilities 
2,695
3,163
0
03,1632,695
> Total Stockholder Equity
-41,536
-48,889
9,297
9,297-48,889-41,536
   Common Stock
2
2
1
122
   Retained Earnings -69,480-49,343-41,966
   Capital Surplus 000
   Treasury Stock000
   Other Stockholders Equity 
428
452
78,773
78,773452428



6.3. Balance Sheets

Currency in USD. All numbers in thousands.




6.4. Cash Flows

Currency in USD. All numbers in thousands.




6.5. Income Statements

All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2022-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue-
Cost of Revenue--
Gross Profit-0
 
Operating Income (+$)
Gross Profit-
Operating Expense--
Operating Income-0
 
Operating Expense (+$)
Research Development-
Selling General Administrative-
Selling And Marketing Expenses-
Operating Expense-0
 
Net Interest Income (+$)
Interest Income-
Interest Expense--
Other Finance Cost-0
Net Interest Income-
 
Pretax Income (+$)
Operating Income-
Net Interest Income-
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-0
EBIT - interestExpense = 0
0
0
Interest Expense-
Earnings Before Interest and Taxes (EBIT)-0
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-
Tax Provision--
Net Income From Continuing Ops-0
Net Income-
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-0
 

Technical Analysis of Phaserx
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Phaserx. The general trend of Phaserx is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Phaserx's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of PhaseRx Inc.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 0.0002 < 0.0002 < 0.0002.

The bearish price targets are: 0.0002 > 0.0002 > 0.0002.

Tweet this
PhaseRx Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of PhaseRx Inc. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

PhaseRx Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of PhaseRx Inc.

PhaseRx Inc Daily Moving Average Convergence/Divergence (MACD) ChartPhaseRx Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of PhaseRx Inc. The current adx is .

PhaseRx Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of PhaseRx Inc.

PhaseRx Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of PhaseRx Inc.

PhaseRx Inc Daily Relative Strength Index (RSI) ChartPhaseRx Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of PhaseRx Inc.

PhaseRx Inc Daily Stochastic Oscillator ChartPhaseRx Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of PhaseRx Inc.

PhaseRx Inc Daily Commodity Channel Index (CCI) ChartPhaseRx Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of PhaseRx Inc.

PhaseRx Inc Daily Chande Momentum Oscillator (CMO) ChartPhaseRx Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of PhaseRx Inc.

PhaseRx Inc Daily Williams %R ChartPhaseRx Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of PhaseRx Inc.

PhaseRx Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of PhaseRx Inc.

PhaseRx Inc Daily Average True Range (ATR) ChartPhaseRx Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of PhaseRx Inc.

PhaseRx Inc Daily On-Balance Volume (OBV) ChartPhaseRx Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of PhaseRx Inc.

PhaseRx Inc Daily Money Flow Index (MFI) ChartPhaseRx Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for PhaseRx Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal

6.3. Candlestick Patterns

PhaseRx Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of PhaseRx Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose0.000
Total0/1 (0.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Phaserx with someone you think should read this too:
  • Are you bullish or bearish on Phaserx? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Phaserx? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about PhaseRx Inc

I send you an email if I find something interesting about PhaseRx Inc.


Comments

How you think about this?

Leave a comment

Stay informed about PhaseRx Inc.

Receive notifications about PhaseRx Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.